UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma
Open Access
- 1 January 2011
- journal article
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 38 (1) , 43-54
Abstract
Besides the current efforts devoted to microbial risk reduction, pathogen inactivation technologies promise reduction of the residual risk of known and emerging infectious agents. A novel pathogen reduction process for platelets, the THERAFLEX UV-Platelets system, has been developed and is under clinical evaluation for its efficacy and safety. In addition, proof of principle has been shown for UVC treatment of plasma units. The pathogen reduction process is based on application of UVC light of a specific wavelength (254 nm) combined with intense agitation of the blood units to ensure a uniform treatment of all blood compartments. Due to the different absorption characteristics of nucleic acids and proteins, UVC irradiation mainly affects the nucleic acid of pathogens and leukocytes while proteins are largely preserved. UVC treatment significantly reduces the infectivity of platelet units contaminated by disease-causing viruses and bacteria. In addition, it inactivates residual white blood cells in the blood components while preserving platelet function and coagulation factors. Since no photoactive compound needs to be added to the blood units, photoreagent-related adverse events are excluded. Because of its simple and rapid procedure without the need to change the established blood component preparation procedures, UVC-based pathogen inactivation could easily be implemented in existing blood banking procedures.Keywords
This publication has 51 references indexed in Scilit:
- BLOOD COMPONENTS: A novel approach to pathogen reduction in platelet concentrates using short‐wave ultraviolet lightTransfusion, 2009
- Inactivation of pathogens in single units of therapeutic fresh plasma by irradiation with ultraviolet lightTransfusion, 2009
- Sterilization of platelet concentrates at production scale by irradiation with short‐wave ultraviolet lightTransfusion, 2009
- Toxicity Testing of a Novel Riboflavin-Based Technology for Pathogen Reduction and White Blood Cell InactivationTransfusion Medicine Reviews, 2008
- Proceedings of a Consensus Conference: Pathogen Inactivation—Making Decisions About New TechnologiesTransfusion Medicine Reviews, 2007
- Photochemical treatment of plasma with amotosalen and long‐wavelength ultraviolet light inactivates pathogens while retaining coagulation functionTransfusion, 2006
- Ultraviolet radiation-mediated damage to cellular DNAMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion modelBlood, 2005
- Continuous-flow UVC irradiation: a new, effective, protein activity-preserving system for inactivating bacteria and viruses, including erythrovirus B19Journal of Virological Methods, 2004
- Inter-strand photoproducts are produced in high yield within A-DNA exposed to UVC radiationNucleic Acids Research, 2003